Neoadjuvant, Adjuvant, or Both? The Debate in NSCLC Rages On Neoadjuvant, Adjuvant, or Both? The Debate in NSCLC Rages On

The question of whether to give upfront immunochemotherapy in resectable non –small cell lung cancer, wait until after surgery, or give both remains a hot topic of debate.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news